NCT05870969View on ClinicalTrials.gov

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

RecruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, ChronicCirrhosis, LiverNon-Alcoholic Fatty Liver Disease
Interventions
BEHAVIORAL

Liver cancer surveillance every 3 months

Follow up every 3 months for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam

BEHAVIORAL

Liver cancer surveillance every 6 months

Follow up every 6 months for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam

BEHAVIORAL

Liver cancer surveillance annually

Follow up annually for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam

Trial Locations (1)

Unknown

RECRUITING

Department of Infectious Diseases , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER